The CD8 T Cell in Multiple Sclerosis: Suppressor Cell Or Mediator of Neuropathology?

International Review of Neurobiology

Volumn 79, Issue , 2007, Pages 73-97

  Johnson, Aaron J ^a   Suidan, Georgette L ^a   McDole, Jeremiah ^a   Pirko, Istvan ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL; BIOLOGICAL MODEL; CD8+ T LYMPHOCYTE; CLASSIFICATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HLA-A ANTIGENS; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 34248659946     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)79004-9     Document Type: Review

References (111)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200 (2002) 629-638
2. Abbott N.J. Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25 (2005) 5-23
3. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., and Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192 (2000) 393-404
4. Baecher-Allan C., and Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212 (2006) 203-216
5. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
6. Begley D.J. Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol. Ther. 104 (2004) 29-45
7. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 6 (2005) 353-360
8. Biegler B.W., Yan S.X., Ortega S.B., Tennakoon D.K., Racke M.K., and Karandikar N.J. Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis. J. Neuroimmunol. 180 1-2 (2006) 159-171
9. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., and Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 Pt. 6 (2000) 1174-1183
10. Blamire A.M., Anthony D.C., Rajagopalan B., Sibson N.R., Perry V.H., and Styles P. Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: A magnetic resonance study. J. Neurosci. 20 (2000) 8153-8159
11. Booss J., Esiri M.M., Tourtellotte W.W., and Mason D.Y. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62 (1983) 219-232
12. Brooks T.A., Hawkins B.T., Huber J.D., Egleton R.D., and Davis T.P. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H738-H743
13. Bruck W., and Stadelmann C. Inflammation and degeneration in multiple sclerosis. Neurol. Sci. 24 Suppl. 5 (2003) S265-S267
14. Butz E.A., and Bevan M.J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8 (1998) 167-175
15. Calzascia T., Masson F., Di Berardino-Besson W., Contassot E., Wilmotte R., Aurrand-Lions M., Ruegg C., Dietrich P.Y., and Walker P.R. Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22 (2005) 175-184
16. Chavarria A., and Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun. Rev. 3 (2004) 251-260
17. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., and Karandikar N.J. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 (2004) 4222-4231
18. Demeuse P., Kerkhofs A., Struys-Ponsar C., Knoops B., Remacle C., and van den Bosch de Aguilar P. Compartmentalized coculture of rat brain endothelial cells and astrocytes: A syngenic model to study the blood-brain barrier. J. Neurosci. Methods 121 (2002) 21-31
19. Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol. Ther. 98 (2003) 245-255
20. Fanning A.S., Mitic L.L., and Anderson J.M. Transmembrane proteins in the tight junction barrier. J. Am. Soc. Nephrol. 10 (1999) 1337-1345
21. Faunce D.E., Terajewicz A., and Stein-Streilein J. Cutting edge: In vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172 (2004) 1991-1995
22. Filaci G., Bacilieri S., Fravega M., Monetti M., Contini P., Ghio M., Setti M., Puppo F., and Indiveri F. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 166 (2001) 6452-6457
23. Fogdell-Hahn A., Ligers A., Gronning M., Hillert J., and Olerup O. Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55 (2000) 140-148
24. Ford M.L., and Evavold B.D. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35 (2005) 76-85
25. French A.R., and Yokoyama W.M. Natural killer cells and autoimmunity. Arthritis Res. Ther. 6 (2004) 8-14
26. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195 (2002) 695-704
27. Gilliet M., Soumelis V., Watanabe N., Hanabuchi S., Antonenko S., de Waal-Malefyt R., and Liu Y.J. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J. Exp. Med. 197 (2003) 1059-1063
28. Giovannoni G., Cutter G.R., Lunemann J., Martin R., Munz C., Sriram S., Steiner I., Hammerschlag M.R., and Gaydos C.A. Infectious causes of multiple sclerosis. Lancet Neurol. 5 (2006) 887-894
29. Green R., Scott L.K., Minagar A., and Conrad S. Sepsis associated encephalopathy (SAE): A review. Front. Biosci. 9 (2004) 1637-1641
30. Harbo H.F., Lie B.A., Sawcer S., Celius E.G., Dai K.Z., Oturai A., Hillert J., Lorentzen A.R., Laaksonen M., Myhr K.M., Ryder L.P., Fredrikson S., et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63 (2004) 237-247
31. Haseloff R.F., Blasig I.E., Bauer H.C., and Bauer H. In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell. Mol. Neurobiol. 25 (2005) 25-39
32. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005) 173-185
33. Hoftberger R., Aboul-Enein F., Brueck W., Lucchinetti C., Rodriguez M., Schmidbauer M., Jellinger K., and Lassmann H. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14 (2004) 43-50
34. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., and Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5 (2004) 516-523
35. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
36. Huseby E.S., White J., Crawford F., Vass T., Becker D., Pinilla C., Marrack P., and Kappler J.W. How the T cell repertoire becomes peptide and MHC specific. Cell 122 (2005) 247-260
37. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., and Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 147 (1999) 1351-1363
38. Jiang H., Zhang S.I., and Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
39. Johnson A.J., Njenga M.K., Hansen M.J., Kuhns S.T., Chen L., Rodriguez M., and Pease L.R. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73 (1999) 3702-3708
40. Johnson A.J., Upshaw J., Pavelko K.D., Rodriguez M., and Pease L.R. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J. 15 (2001) 2760-2762
41. Johnson A.J., Mendez-Fernandez Y., Moyer A.M., Sloma C.R., Pirko I., Block M.S., Rodriguez M., and Pease L.R. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J. Immunol. 174 (2005) 6854-6862
42. Jurewicz A., Biddison W.E., and Antel J.P. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160 (1998) 3056-3059
43. Kantarci O.H., and Weinshenker B.G. Natural history of multiple sclerosis. Neurol. Clin. 23 (2005) 17-38
44. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., Lovett-Racke A.E., Frohman E.M., Stastny P., Douek D.C., Koup R.A., and Racke M.K. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 109 (2002) 641-649
45. Karman J., Ling C., Sandor M., and Fabry Z. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173 (2004) 2353-2361
46. Khanna K.M., Bonneau R.H., Kinchington P.R., and Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18 (2003) 593-603
47. Killestein J., Den Drijver B.F., Van der Graaff W.L., Uitdehaag B.M., Polman C.H., and Van Lier R.A. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: Different features in primary progressive disease. Mult. Scler. 7 (2001) 145-150
48. Killestein J., Eikelenboom M.J., Izeboud T., Kalkers N.F., Ader H.J., Barkhof F., Van Lier R.A., Uitdehaag B.M., and Polman C.H. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS. J. Neuroimmunol. 142 (2003) 141-148
49. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., and Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172 (2004) 3297-3304
50. Kirk J., Plumb J., Mirakhur M., and McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 201 (2003) 319-327
51. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., and Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256 (1992) 1210-1213
52. Kubota K., Furuse M., Sasaki H., Sonoda N., Fujita K., Nagafuchi A., and Tsukita S. Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr. Biol. 9 (1999) 1035-1038
53. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., and Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
54. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Meager A., Janus J., and Ennis F.A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 88 (1991) 1473-1480
55. Kurtzke J.F., and Heltberg A. Multiple sclerosis in the Faroe islands: An epitome. J. Clin. Epidemiol. 54 (2001) 1-22
56. Lassmann H., and Ransohoff R.M. The CD4-Th1 model for multiple sclerosis: A critical [correction of crucial] re-appraisal. Trends Immunol. 25 (2004) 132-137
57. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., and Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
58. Liu T., Khanna K.M., Chen X., Fink D.J., and Hendricks R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191 (2000) 1459-1466
59. Loke H., Bethell D.B., Phuong C.X., Dung M., Schneider J., White N.J., Day N.P., Farrar J., and Hill A.V. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword?. J. Infect. Dis. 184 (2001) 1369-1373
60. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
61. Lucchinetti C.F., Bruck W., and Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann. Neurol. 56 (2004) 308
62. Madakamutil L.T., Maricic I., Sercarz E., and Kumar V. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 170 (2003) 2985-2992
63. Markovic-Plese S., and McFarland H.F. Immunopathogenesis of the multiple sclerosis lesion. Curr. Neurol. Neurosci. Rep. 1 (2001) 257-262
64. Medana I., Martinic M.A., Wekerle H., and Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159 (2001) 809-815
65. Medana I.M., and Turner G.D. Human cerebral malaria and the blood-brain barrier. Int. J. Parasitol. 36 (2006) 555-568
66. Medana I.M., Gallimore A., Oxenius A., Martinic M.M., Wekerle H., and Neumann H. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 30 (2000) 3623-3633
67. Minagar A., and Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9 (2003) 540-549
68. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P.T., McMichael A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9 (2003) 921-927
69. Monteiro J., Hingorani R., Pergolizzi R., Apatoff B., and Gregersen P.K. Clonal dominance of CD8+ T-cell in multiple sclerosis. Ann. N Y Acad. Sci. 756 (1995) 310-312
70. Moses Jr. H., and Sriram S. An infectious basis for multiple sclerosis: Perspectives on the role of Chlamydia pneumoniae and other agents. BioDrugs 15 (2001) 199-206
71. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., Slansky J., and Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8 (1998) 177-187
72. Murray P.D., McGavern D.B., Lin X., Njenga M.K., Leibowitz J., Pease L.R., and Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18 (1998) 7306-7314
73. Najafian N., Chitnis T., Salama A.D., Zhu B., Benou C., Yuan X., Clarkson M.R., Sayegh M.H., and Khoury S.J. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J. Clin. Invest. 112 (2003) 1037-1048
74. Nelson A.L., Bieber A.J., and Rodriguez M. Contrasting murine models of MS. Int. MS J. 11 (2004) 95-99
75. Neumann H., Cavalie A., Jenne D.E., and Wekerle H. Induction of MHC class I genes in neurons. Science 269 (1995) 549-552
76. Neumann H., Medana I.M., Bauer J., and Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25 (2002) 313-319
77. Neville K.L., Padilla J., and Miller S.D. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: Implications for the treatment of MS. J. Neuroimmunol. 123 (2002) 18-29
78. Niland B., Banki K., Biddison W.E., and Perl A. CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis. J. Immunol. 175 (2005) 8365-8378
79. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
80. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., and Platsoucas C.D. Theiler's virus infection: A model for multiple sclerosis. Clin. Microbiol. Rev. 17 (2004) 174-207
81. Oshima T., Laroux F.S., Coe L.L., Morise Z., Kawachi S., Bauer P., Grisham M.B., Specian R.D., Carter P., Jennings S., Granger D.N., Joh T., et al. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc. Res. 61 (2001) 130-143
82. Petereit H.F., Pukrop R., Fazekas F., Bamborschke S.U., Ropele S., Kolmel H.W., Merkelbach S., Japp G., Jongen P.J., Hartung H.P., and Hommes O.R. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J. Neurol. Sci. 206 (2003) 209-214
83. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: Permeability changes in neuroinflammation. Prog. Neurobiol. 68 (2002) 311-323
84. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., and Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4 (1998) 187-193
85. Savinov A.Y., Wong F.S., Stonebraker A.C., and Chervonsky A.V. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J. Exp. Med. 197 (2003) 643-656
86. Sepulcre J., Sanchez-Ibarrola A., Moreno C., and de Castro P. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis. Cytokine 32 (2005) 111-116
87. Shacklett B.L., Cox C.A., Wilkens D.T., Karl Karlsson R., Nilsson A., Nixon D.F., and Price R.W. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Infect. Dis. 189 (2004) 2202-2212
88. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., Wekerle H., Hohlfeld R., and Goebels N. Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101 (2004) 2428-2433
89. Smeltz R.B., Wolf N.A., and Swanborg R.H. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: Implications for autoimmunity. J. Immunol. 163 (1999) 1390-1397
90. Solomon T., Dung N.M., Vaughn D.W., Kneen R., Thao L.T., Raengsakulrach B., Loan H.T., Day N.P., Farrar J., Myint K.S., Warrell M.J., James W.S., et al. Neurological manifestations of dengue infection. Lancet 355 (2000) 1053-1059
91. Steinman L., and Zamvil S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26 (2005) 565-571
92. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006) 12-21
93. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., Rothman A.L., Ennis F.A., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 (2002) 309-318
94. Stoll G., Jander S., and Schroeter M. Cytokines in CNS disorders: Neurotoxicity versus neuroprotection. J. Neural. Transm. Suppl. 59 (2000) 81-89
95. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., and Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
96. Tallquist M.D., Yun T.J., and Pease L.R. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184 (1996) 1017-1026
97. Theil D.J., Tsunoda I., Rodriguez F., Whitton J.L., and Fujinami R.S. Viruses can silently prime for and trigger central nervous system autoimmune disease. J. Neurovirol. 7 (2001) 220-227
98. Tsuchida T., Parker K.C., Turner R.V., McFarland H.F., Coligan J.E., and Biddison W.E. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91 (1994) 10859-10863
99. Tsukita S., Furuse M., and Itoh M. Structural and signalling molecules come together at tight junctions. Curr. Opin. Cell Biol. 11 (1999) 628-633
100. Ure D.R., and Rodriguez M. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience 111 (2002) 399-411
101. Weiner H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61 (2004) 1613-1615
102. Wingerchuk D.M. Neuromyelitis optica: Current concepts. Front. Biosci. 9 (2004) 834-840
103. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 (1999) 1107-1114
104. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
105. Wolburg H., and Lippoldt A. Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul. Pharmacol. 38 (2002) 323-337
106. Wong D., Dorovini-Zis K., and Vincent S.R. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp. Neurol. 190 (2004) 446-455
107. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., Shastri N., Pamer E.G., and Janeway Jr. C.A. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5 (1999) 1026-1031
108. Zamvil S.S., and Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8 (1990) 579-621
109. Zang Y.C., Li S., Rivera V.M., Hong J., Robinson R.R., Breitbach W.T., Killian J., and Zhang J.Z. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172 (2004) 5120-5127
110. Zhang D., Beresford P.J., Greenberg A.H., and Lieberman J. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc. Natl. Acad. Sci. USA 98 (2001) 5746-5751
111. Zivna I., Green S., Vaughn D.W., Kalayanarooj S., Stephens H.A., Chandanayingyong D., Nisalak A., Ennis F.A., and Rothman A.L. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168 (2002) 5959-5965